Close Menu

NEW YORK — Volpara Health Technologies said on Wednesday that its Volpara Solutions subsidiary has signed an agreement to link its cancer screening and practice management platform with Ambry Genetics' program for identifying high-risk breast cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.